1 Min Read
Feb 7 (Reuters) - Lupin Ltd:
* JV YL BIOLOGICS SAYS PHASE III CLINICAL TRIAL OF INVESTIGATIONAL ETANERCEPT BIOSIMILAR (YLB113) HAS MET WITH SUCCESSFUL OUTCOME Source text: bit.ly/2GUNAnF Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.